Karl‐Ludwig Laugwitz
-
- Antiplatelet Therapy and Cardiovascular Diseases 8
- Acute Myocardial Infarction Research 6
- Cardiac electrophysiology and arrhythmias 5
- Cardiac Valve Diseases and Treatments 5
- Hematology top 5%
- Internal Medicine top 10%
- Molecular Biology top 10%
- Receptor Mechanisms and Signaling 7
-
- Coronary Interventions and Diagnostics 18
- Peripheral Artery Disease Management 7
-
- Cardiac Imaging and Diagnostics 9
- Co-authors
- Karsten SpicherStefan OffermannsG. SchultzAnouk AllgeierGlauco SchultzJ. Van SandeJ.E. DumontThomas Gudermann
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (1 paper)Circulation (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Karl‐Ludwig Laugwitz
48 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Cardiology and Cardiovascular Medicine 448
- Cellular and Molecular Neuroscience 356
- Hematology 209
- Internal Medicine 50
- Molecular Biology 864
Countries citing papers authored by Karl‐Ludwig Laugwitz
This map shows the geographic impact of Karl‐Ludwig Laugwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl‐Ludwig Laugwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl‐Ludwig Laugwitz more than expected).
Fields of papers citing papers by Karl‐Ludwig Laugwitz
This network shows the impact of papers produced by Karl‐Ludwig Laugwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl‐Ludwig Laugwitz. The network helps show where Karl‐Ludwig Laugwitz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karl‐Ludwig Laugwitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 17 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 25 | |
| 10 | 2022 | 0 | |
| 11 | 2022 | 0 | |
| 12 | 2022 | 0 | |
| 13 | 2021 | 9 | |
| 14 | 2019 | 7 | |
| 15 | 2018 | 1 | |
| 16 | 2017 | 12 | |
| 17 | 2008 | 13 | |
| 18 | 1998 | 50 | |
| 19 | 1997 | 21 | |
| 20 | 1997 | 3 |
About Karl‐Ludwig Laugwitz
Karl‐Ludwig Laugwitz is a scholar working on Health Informatics, Cardiology and Cardiovascular Medicine and Internal Medicine, having authored 56 papers that have together received 1.5k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (18 papers), Cardiac Imaging and Diagnostics (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Peripheral Artery Disease Management (7 papers), Receptor Mechanisms and Signaling (7 papers), Acute Myocardial Infarction Research (6 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Cardiac Valve Diseases and Treatments (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (448 citations), Cellular and Molecular Neuroscience (356 citations) and Hematology (209 citations). Karl‐Ludwig Laugwitz has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Karsten Spicher, Stefan Offermanns, G. Schultz, Anouk Allgeier, Glauco Schultz, J. Van Sande, J.E. Dumont, Thomas Gudermann, Alessandra Moretti and Milena Bellin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.